BSE Live
Dec 10, 11:56Prev. Close
190.10
Open Price
189.95
Bid Price (Qty.)
188.55 (209)
Offer Price (Qty.)
188.85 (149)
NSE Live
Dec 10, 11:56Prev. Close
190.11
Open Price
189.61
Bid Price (Qty.)
188.64 (63)
Offer Price (Qty.)
188.76 (54)
| Cash Flow of Marksans Pharma (in Rs. Cr.) | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 | |
| 12 mths | 12 mths | 12 mths | 12 mths | 12 mths | ||
| Net Profit/Loss Before Extraordinary Items And Tax | 243.26 | 171.89 | 132.04 | 134.51 | 124.33 | |
| Net CashFlow From Operating Activities | 31.02 | 34.05 | 51.73 | 50.97 | 107.07 | |
| Net Cash Used In Investing Activities | 17.24 | -114.22 | -194.62 | -8.40 | 8.82 | |
| Net Cash Used From Financing Activities | -29.92 | -26.22 | 210.02 | 75.86 | -13.53 | |
| Foreign Exchange Gains / Losses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Adjustments On Amalgamation Merger Demerger Others | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Net Inc/Dec In Cash And Cash Equivalents | 18.34 | -106.38 | 67.12 | 118.44 | 102.36 | |
| Cash And Cash Equivalents Begin of Year | 41.93 | 148.31 | 81.19 | 105.61 | 3.35 | |
| Cash And Cash Equivalents End Of Year | 60.27 | 41.93 | 148.31 | 224.05 | 105.71 |
26.11.2025
Marksans Pharma Consolidated September 2025 Net Sales at Rs 720.41 crore, up 12.23% Y-o-Y
24.11.2025
Marksans Pharma Standalone September 2025 Net Sales at Rs 320.44 crore, up 3.83% Y-o-Y
09.09.2025
Marksans Pharma Standalone June 2025 Net Sales at Rs 319.73 crore, up 25.62% Y-o-Y
20.05.2025
Marksans Pharma Consolidated March 2025 Net Sales at Rs 708.46 crore, up 26.51% Y-o-Y